Literature DB >> 16723590

Diminished macrophage inflammatory response to Staphylococcus aureus isolates exposed to daptomycin versus vancomycin or oxacillin.

B Keith English1, Erik M Maryniw, Ajay J Talati, Elizabeth A Meals.   

Abstract

Exposure of any of six clinical isolates of Staphylococcus aureus to daptomycin alone or in combination with vancomycin or oxacillin (compared with vancomycin or oxacillin alone) led to a dampened macrophage inflammatory response with diminished tumor necrosis factor secretion and reduced accumulation of inducible nitric oxide synthase protein.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16723590      PMCID: PMC1479096          DOI: 10.1128/AAC.01559-05

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  In vitro bactericidal activity of daptomycin against staphylococci.

Authors:  Peter C Fuchs; Arthur L Barry; Steven D Brown
Journal:  J Antimicrob Chemother       Date:  2002-03       Impact factor: 5.790

2.  Daptomycin disrupts membrane potential in growing Staphylococcus aureus.

Authors:  W E Alborn; N E Allen; D A Preston
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

3.  Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk.

Authors:  B C Herold; L C Immergluck; M C Maranan; D S Lauderdale; R E Gaskin; S Boyle-Vavra; C D Leitch; R S Daum
Journal:  JAMA       Date:  1998-02-25       Impact factor: 56.272

Review 4.  Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis.

Authors:  Roland Nau; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

5.  Group B streptococci exposed to rifampin or clindamycin (versus ampicillin or cefotaxime) stimulate reduced production of inflammatory mediators by murine macrophages.

Authors:  Kevin C Brinkmann; Ajay J Talati; Raumina E Akbari; Elizabeth A Meals; B Keith English
Journal:  Pediatr Res       Date:  2005-01-05       Impact factor: 3.756

Review 6.  Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections.

Authors:  Judith N Steenbergen; Jeff Alder; Grace M Thorne; Francis P Tally
Journal:  J Antimicrob Chemother       Date:  2005-02-10       Impact factor: 5.790

7.  Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus.

Authors:  Blanca E Gonzalez; Gerardo Martinez-Aguilar; Kristina G Hulten; Wendy A Hammerman; Jorge Coss-Bu; Anna Avalos-Mishaan; Edward O Mason; Sheldon L Kaplan
Journal:  Pediatrics       Date:  2005-03       Impact factor: 7.124

8.  Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children's Hospital.

Authors:  Steven C Buckingham; Linda K McDougal; Lorene D Cathey; Katha Comeaux; Allen S Craig; Scott K Fridkin; Fred C Tenover
Journal:  Pediatr Infect Dis J       Date:  2004-07       Impact factor: 2.129

9.  Pneumococci stimulate the production of the inducible nitric oxide synthase and nitric oxide by murine macrophages.

Authors:  K L Orman; J L Shenep; B K English
Journal:  J Infect Dis       Date:  1998-12       Impact factor: 5.226

Review 10.  Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens.

Authors:  Christopher F Carpenter; Henry F Chambers
Journal:  Clin Infect Dis       Date:  2004-03-11       Impact factor: 9.079

View more
  13 in total

1.  Actions of N-acetylcysteine, daptomycin, vancomycin, and linezolid on methicillin-resistant Staphylococcus aureus biofilms in the ventriculoperitoneal shunt infections: an experimental study.

Authors:  Tuba Kuruoglu; Gamze Altun; Enis Kuruoglu; Derya Bayırlı Turan; Mehmet Emin Önger
Journal:  Chin Neurosurg J       Date:  2022-07-05

Review 2.  The Role of Antibiotics in Modulating Virulence in Staphylococcus aureus.

Authors:  Elisabeth Hodille; Warren Rose; Binh An Diep; Sylvain Goutelle; Gerard Lina; Oana Dumitrescu
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132

3.  Clinical features and outcome of patients with descending necrotizing mediastinitis: prospective analysis of 34 cases.

Authors:  Daniela M Palma; Simone Giuliano; Andrea N Cracchiolo; Marco Falcone; Giancarlo Ceccarelli; Romano Tetamo; Mario Venditti
Journal:  Infection       Date:  2015-09-03       Impact factor: 3.553

4.  Improving therapeutic strategies for secondary bacterial pneumonia following influenza.

Authors:  Jonathan A McCullers; B Keith English
Journal:  Future Microbiol       Date:  2008-08       Impact factor: 3.165

Review 5.  Daptomycin: a review of its use in the management of complicated skin and soft-tissue infections and Staphylococcus aureus bacteraemia.

Authors:  Philip I Hair; Susan J Keam
Journal:  Drugs       Date:  2007       Impact factor: 9.546

6.  Ketamine inhibits tumor necrosis factor secretion by RAW264.7 murine macrophages stimulated with antibiotic-exposed strains of community-associated, methicillin-resistant Staphylococcus aureus.

Authors:  Thomas Spentzas; Rebekah K H Shapley; Carlos Acuna Aguirre; Elizabeth Meals; Lauren Lazar; Mark S Rayburn; Brett S Walker; B Keith English
Journal:  BMC Immunol       Date:  2011-01-25       Impact factor: 3.615

7.  Linezolid, vancomycin and daptomycin modulate cytokine production, Toll-like receptors and phagocytosis in a human in vitro model of sepsis.

Authors:  Christian Bode; Stefan Muenster; Britta Diedrich; Sebastian Jahnert; Christina Weisheit; Folkert Steinhagen; Olaf Boehm; Andreas Hoeft; Rainer Meyer; Georg Baumgarten
Journal:  J Antibiot (Tokyo)       Date:  2015-03-04       Impact factor: 2.649

8.  Daptomycin in experimental murine pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Mark S Rouse; Cheol-In Kang; Diederik van de Beek; James M Steckelberg; Robin Patel
Journal:  BMC Infect Dis       Date:  2009-04-30       Impact factor: 3.090

9.  The efficacy and safety of daptomycin vs. vancomycin for the treatment of cellulitis and erysipelas.

Authors:  P E Pertel; B I Eisenstein; A S Link; B Donfrid; E J A Biermann; P Bernardo; W J Martone
Journal:  Int J Clin Pract       Date:  2009-03       Impact factor: 2.503

10.  Rapamycin Augments the NMDA-Mediated TNF Suppression of MRSA-Stimulated RAW264.7 Murine Macrophages.

Authors:  Thomas Spentzas; Rebekah K H Shappley; Fabio Savorgnan; Elizabeth Meals; B Keith English
Journal:  Int J Inflam       Date:  2012-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.